- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Imatinib Mesylate (Gleevec)
Total 2815 results
-
Novartis PharmaceuticalsCompletedGastrointestinal Stromal TumorsJapan
-
Rennes University HospitalNovartis; Ministry of Health, FranceCompletedAcute Lymphoblastic Leukemia | Philadelphia ChromosomeFrance
-
Novartis PharmaceuticalsCompletedAcute Myeloid Leukemia | Acute Lymphoblastic Leukemia | Philadelphia Positive Chronic Myeloid LeukemiaUnited States, Germany, United Kingdom, France, Italy
-
Centre Leon BerardCompletedGastrointestinal Stromal Tumors | Resected Gastrointestinal Stromal Tumors | Non-metastatic | High Risk of Recurrence | KIT Gene MutationFrance
-
Sarcoma Alliance for Research through CollaborationCompletedDermatofibrosarcoma ProtuberansUnited States
-
Novartis PharmaceuticalsCompletedPhiladelphia Chromosome Positive Acute Lymphocytic Leukemia
-
Novartis PharmaceuticalsTerminatedChronic Myeloid Leukemia (CML) | Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ ALL) | Other Glivec/Gleevec Indicated Hematological Disorders (HES, CEL, MDS/ MPN)Russian Federation
-
King Faisal Specialist Hospital & Research CenterCompleted
-
Massachusetts General HospitalNovartis PharmaceuticalsCompletedNephrogenic Systemic FibrosisUnited States
-
Bristol-Myers SquibbCompletedLeukemiaGermany, Italy, Korea, Republic of, Sweden, Thailand, United States, Australia, France, Poland, Switzerland, Spain, Ireland, Peru, Brazil, South Africa, Canada, Argentina, Hungary, Finland, Israel, Norway, Russian Federation, United... and more
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)CompletedAccelerated Phase Chronic Myelogenous Leukemia | Adult Acute Lymphoblastic Leukemia in Remission | Childhood Acute Lymphoblastic Leukemia in Remission | Childhood Chronic Myelogenous Leukemia | Chronic Phase Chronic Myelogenous Leukemia | Recurrent Adult Acute Lymphoblastic Leukemia | Recurrent... and other conditionsUnited States
-
Gustave Roussy, Cancer Campus, Grand ParisTerminated
-
Lawson Health Research InstituteNovartis PharmaceuticalsTerminated
-
Jewish General HospitalNovartis PharmaceuticalsTerminatedChronic Lymphocytic LeukemiaCanada
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedMelanoma | Skin NeoplasmsUnited States
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.CompletedChronic Myeloid LeukemiaChina
-
Dana-Farber Cancer InstituteNovartis; Brigham and Women's HospitalCompletedT Cell Non-Hodgkin LymphomaUnited States
-
University of LiverpoolImperial College London; Newcastle University; University of GlasgowUnknownChronic Myeloid LeukaemiaUnited Kingdom
-
SCRI Development Innovations, LLCNovartis; Genentech, Inc.CompletedClear Cell Renal Cell Carcinoma
-
M.D. Anderson Cancer CenterJohnson & Johnson Pharmaceutical Research & Development, L.L.C.CompletedLeukemia, Myeloid, ChronicUnited States
-
University of Michigan Rogel Cancer CenterTerminated
-
National Cancer Institute (NCI)CompletedChronic Phase Chronic Myelogenous Leukemia | Relapsing Chronic Myelogenous Leukemia | Chronic Myelogenous Leukemia, BCR-ABL1 PositiveUnited States
-
M.D. Anderson Cancer CenterNovartis PharmaceuticalsTerminatedMyelogenous Leukemia, Chronic, Chronic PhaseUnited States
-
M.D. Anderson Cancer CenterAbiogen PharmaTerminatedChronic Myelogenous LeukemiaUnited States
-
National Cancer Institute (NCI)Completed
-
National Cancer Institute (NCI)TerminatedGastrointestinal Stromal TumorUnited States
-
Dana-Farber Cancer InstituteNovartisCompletedMucosal Melanoma | Acral/Lentiginous Melanoma | Chronically Sun Damaged MelanomasUnited States
-
University of California, Los AngelesNovartis PharmaceuticalsCompletedSystemic Sclerosis | AlveolitisUnited States
-
Indiana University School of MedicineCompletedThymic CarcinomaUnited States
-
Peking UniversityNovartisCompletedMetastatic MelanomaChina
-
Northern Italy Leukemia GroupCompletedHypereosinophilic Syndrome | Chronic Eosinophilic Leukemia | Chronic Idiopathic HypereosinophiliaItaly
-
David MiklosNovartisCompletedGraft vs Host DiseaseUnited States
-
Duke UniversityNovartis PharmaceuticalsCompletedGlioblastoma | GliosarcomaUnited States
-
Oncology Specialists, S.C.CompletedProstate CancerUnited States
-
National Cancer Institute (NCI)CompletedAccelerated Phase Chronic Myelogenous Leukemia | Childhood Chronic Myelogenous Leukemia | Relapsing Chronic Myelogenous Leukemia | Chronic Myelogenous Leukemia, BCR-ABL1 Positive | Blastic Phase Chronic Myelogenous LeukemiaUnited States
-
Asan Medical CenterCompletedSarcoma | Gastrointestinal Stromal TumorsKorea, Republic of
-
Peking UniversityCompletedGastrointestinal Stromal TumorChina
-
Institut BergoniéNovartisTerminatedLeukemia, Myeloid, Chronic-PhaseFrance
-
University of WashingtonNational Cancer Institute (NCI)CompletedStage IIIB Non-small Cell Lung Cancer | Recurrent Non-small Cell Lung Cancer | Stage IV Non-small Cell Lung Cancer | Malignant Pleural EffusionUnited States
-
Memorial Sloan Kettering Cancer CenterActive, not recruitingGastrointestinal Stromal Tumor (GIST)United States
-
Annick DesjardinsAstraZeneca; Novartis PharmaceuticalsCompletedGlioblastoma | GliosarcomaUnited States
-
Heikki JoensuuScandinavian Sarcoma GroupActive, not recruiting
-
Amneal Pharmaceuticals, LLCAccutest Research Laboratories (I) Pvt. Ltd.CompletedChronic Myeloid Leukemia | Gastrointestinal Stromal TumorIndia
-
Abramson Cancer Center at Penn MedicineNovartis PharmaceuticalsTerminated
-
Medical University of South CarolinaColumbia UniversityCompleted
-
Baylor College of MedicineRecruitingChronic Myeloid Leukemia | Chronic Myeloid Leukemia, BCR/ABL-Positive, in Remission | Chronic Myeloid Leukemia in RemissionUnited States
-
Poitiers University HospitalCompleted
-
Seoul St. Mary's HospitalNovartisUnknownChronic Myeloid LeukemiaKorea, Republic of
-
Hospital Universitario Dr. Jose E. GonzalezNovartis PharmaceuticalsCompletedLeukemia, Myeloid, Chronic, BCR-ABL PositiveMexico
-
M.D. Anderson Cancer CenterCompleted